Related Experiment Video
Updated: Oct 16, 2025

06:23
Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota
Published on: February 15, 2019
14.4K
Predicting the Role of the Human Gut Microbiome in Constipation Using Machine-Learning Methods: A Meta-Analysis
Yutao Chen1,2, Tong Wu1,2, Wenwei Lu1,2
1State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
Microorganisms
|October 23, 2021
Summary
This study reveals distinct gut microbiome differences in constipation patients, identifying key bacterial biomarkers like Serratia and Dorea. A machine learning model accurately classifies constipation based on fecal bacteria.
Area of Science:
- Microbiology
- Gastroenterology
- Bioinformatics
Background:
- Constipation significantly impacts patient health and quality of life.
- Emerging research links gut microbiome alterations to constipation, but often lacks multi-cohort validation.
- Understanding these links is crucial for developing novel diagnostic and therapeutic strategies.
Purpose of the Study:
- To construct a robust classification model for constipation using fecal bacterial data.
- To identify specific gut microbial species that can serve as biomarkers for constipation.
- To validate findings across multiple independent research cohorts.
Main Methods:
- Analysis of 3056 fecal amplicon sequence datasets from five distinct cohorts.
- Comprehensive microbiome analysis including alpha- and beta-diversity, and phylogenetic profiling.
- Application of machine learning, specifically Gradient Boosted Regression Trees with chi2 feature selection, for model development.
Main Results:
- Patients with constipation exhibited significantly higher alpha diversity in their gut bacterial communities.
- Distinct differences in gut microbiota composition were observed between constipated and non-constipated individuals (beta diversity).
- The developed machine learning model achieved a 70.7% validation accuracy in classifying constipation.
Conclusions:
- A reliable discriminant model for constipation has been established based on fecal microbiome data.
- Fifteen key bacterial genera, including Serratia, Dorea, and Aeromonas, were identified as potential biomarkers for constipation.
- These findings highlight the gut microbiome's role in constipation and offer potential for targeted interventions.
Related Concept Videos
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
179
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
179
Anatomy of the Intestines
84.2K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
84.2K
Drugs for Treatment of Constipation-Predominant IBS
387
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
387

